Last Update 24 Jun 26
Fair value Increased 0.073%LIN: Pricing Power And Space Exposure Will Support Fairly Valued Gas Portfolio
Linde’s updated analyst price target edges higher, with a modest fair value increase to about $545 and fresh Street research, including multiple recent target raises toward $600. These changes reflect analysts’ refined views on its long term earnings profile and P/E assumptions.
Analyst Commentary
Recent Street research around Linde highlights a cluster of higher price targets, including several moves toward US$600, as analysts refresh their earnings models and P/E assumptions ahead of upcoming results. For you as an investor, the key is less the exact target and more what these shifts say about how Linde’s valuation and execution are being viewed.
Bullish Takeaways
- Bullish analysts are clustering price targets in a higher range, including a recent move to US$600, which signals increased conviction in Linde’s long term earnings profile relative to current pricing.
- Multiple price target raises across the Q2 preview period suggest that recent data points and management updates are being incorporated into models in a way that supports a higher assumed P/E.
- The use of Linde in an overweight leg of a pair trade against a sector peer indicates some analysts see better risk reward in Linde’s execution and cash flow potential versus alternatives in industrial gases and specialty chemicals.
- The repeated upward revisions from several research shops imply that, within the sector, Linde is being treated as one of the core large cap holdings when institutions think about exposure to industrial gases.
Bearish Takeaways
- Despite higher targets, the Street still frames Linde within peer-relative trades, which points to ongoing scrutiny around whether its premium P/E assumptions remain justified if sector conditions tighten.
- The frequent fine tuning of targets in increments of US$5 to US$50 shows that a lot of the debate is around model sensitivities, so small changes in growth or margin assumptions could have a visible impact on perceived fair value.
- With targets now extending toward US$600, the gap between current trading levels and analyst fair value estimates may narrow if execution or earnings delivery falls short of expectations.
- Concentration of opinion around a bullish case can increase the risk that any negative surprise on earnings quality or project timing triggers sharper reassessment of Linde’s valuation than in a more balanced setup.
What’s in the News for Linde
- Linde is highlighted as a key industrial gas supplier to SpaceX, providing liquid oxygen for about 70% of the company’s rocket launches. Analysts flag the commercial space sector as an important driver for future revenue and volume growth. Source: Multiple reports summarized in recent coverage.
- Analysts cite SpaceX’s shift toward more propellant intensive Starship rockets and rising launch frequency as potential volume drivers for Linde’s liquid oxygen business. They also note the growing use of its industrial gases in semiconductors, emissions control, and food processing. Source: UBS, Rothschild and other research cited in recent news.
- Linde reported Q1 2026 earnings and revenue above prior expectations and raised the lower end of its full year earnings guidance. Management commentary pointed to favorable pricing and steady demand across U.S. refining, electronics, and manufacturing, as well as expanding opportunities in hydrogen, industrial gases, and commercial space. Source: Recent earnings coverage.
- The company outlined growth projects including the planned 2027 commissioning of the Woodside hydrogen and nitrogen supply plant for blue ammonia production and a US$7.1b gas backlog under construction. Management also commented on improving helium market conditions. Source: Recent earnings coverage.
- Linde reported that from January 1, 2026 to March 31, 2026 it repurchased 1,662,000 shares for US$791.41m, completing the buyback of 18,859,424 shares for US$8,490.75m under the program announced on October 23, 2023. The company separately announced a new air separation unit in Garysburg, North Carolina that is expected to start up at the end of 2028. Source: Company filings and announcements.
Valuation Changes for Linde
- Fair Value: $545.44, essentially unchanged from $545.04, with only a very small upward adjustment in the model.
- Discount Rate: 7.87%, up slightly from 7.85%, indicating a modestly higher required return in the updated assumptions.
- Revenue Growth: 5.78%, effectively flat versus the prior 5.78%, suggesting very limited change in Linde’s top line growth outlook within the model.
- Net Profit Margin: 23.06%, steady with only a very small upward move from 23.06%, keeping the profitability profile broadly consistent.
- Future P/E: 32.13x, up marginally from 32.09x, reflecting a slightly higher valuation multiple applied to Linde’s projected earnings.
8 viewsusers have viewed this narrative update
Key Takeaways
- Expansion in clean energy, electronics, and emerging markets positions Linde for sustained growth and structurally higher margins through strategic investments and long-term contracts.
- Focus on digitalization, operational efficiency, and decarbonization trends drives margin improvement, resilient cash flow, and benefits from global regulatory support.
- Structural risks from weak industrial demand, oversupply pressures, and an uncertain energy transition threaten Linde's revenue growth, pricing power, and long-term profitability.
Catalysts
About Linde- Operates as an industrial gas company in the United States, China, Germany, the United Kingdom, Australia, Mexico, Brazil, and internationally.
- Linde's project backlog has doubled over the last 4 years-anchored by long-term, fixed-fee contracts supporting U.S. clean energy and electronics infrastructure-and management expects this robust pipeline to remain at record levels, positioning the company for steady multi-year revenue and earnings growth.
- Strategic investments and customer commitments in rapidly expanding growth markets such as commercial space launches, electronics, and clean hydrogen (with almost $5 billion in new clean energy contracts) provide a runway for high-margin revenue streams and new project conversion that will structurally lift blended margins and earnings.
- Linde's ongoing focus on digitalization, operational optimization, and network density-including base volume growth CapEx and bolt-on M&A-should continue to drive self-help margin improvement and support strong operating cash flow and net margin expansion, even through cyclical downturns.
- Structural tailwinds from the global push for decarbonization, demand for low-carbon hydrogen/ammonia, and ongoing regulatory/incentive support (e.g., enhanced tax credits like 45Q and bonus depreciation in the U.S.) are expected to accelerate both revenue and project IRRs for years as energy transition investments continue.
- The increasing need for medical and specialty gases in emerging markets (notably APAC and India), coupled with an aging global population and higher healthcare standards, supports long-term, stable growth in high-value segments and underpins future recurring revenue and cash flow stability.
Linde Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Linde's revenue will grow by 5.8% annually over the next 3 years.
- Analysts assume that profit margins will increase from 20.4% today to 23.1% in 3 years time.
- Analysts expect earnings to reach $9.5 billion (and earnings per share of $21.32) by about June 2029, up from $7.1 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $10.6 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 32.1x on those 2029 earnings, down from 33.4x today. This future PE is greater than the current PE for the US Chemicals industry at 25.8x.
- Analysts expect the number of shares outstanding to decline by 1.35% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.87%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Persistent deindustrialization and economic weakness in Europe, including potential chemical and manufacturing plant closures, present a long-term structural risk for Linde, which could lead to sustained volume declines and revenue contraction in the region and erode network density, impacting profitability.
- Ongoing global economic uncertainty and weak industrial activity in key markets, especially in Europe and parts of Asia-Pacific, heighten the risk of prolonged or worsening negative base volume growth, which may suppress revenue and EPS growth if industrial recovery remains slow.
- Oversupply and price pressures in certain product lines (e.g., helium in China and Asia), as well as evolving competition from regional players or new market entrants in commoditized gases, could create downward pressure on pricing and net margins, reducing overall profitability.
- Despite a robust low-carbon project backlog, the energy transition in Europe and globally may progress slower than anticipated due to regulatory delays, pragmatism over targets, and long permitting/infrastructure timelines; this uncertainty about the pace of clean energy adoption could hinder long-term sales growth from new projects and impact returns on invested capital.
- Large, long-term contracts-especially for on-site supply in cyclical or declining industries-can insulate near-term earnings but pose a risk of future revenue volatility and margin compression if structural demand for gases weakens in core end markets (steel, refining, chemicals), or if customers fall below minimum take-or-pay thresholds over time.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $545.44 for Linde based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $600.0, and the most bearish reporting a price target of just $400.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $41.0 billion, earnings will come to $9.5 billion, and it would be trading on a PE ratio of 32.1x, assuming you use a discount rate of 7.9%.
- Given the current share price of $512.26, the analyst price target of $545.44 is 6.1% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Linde?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Read more narratives
There are no other narratives for this company.
View all narratives